“We have a tenant” a right atrial thrombus related to a central catheter

Bayón, Jeremías; Martı́n, Marı́a; García-Ruiz, José M.; Rodríguez, Concepción Fernández

doi:10.1007/s10554-010-9636-x

Cited by 15 publications

(8 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our search produced a total of eight case series encompassing 32 cases and 32 additional individual case reports. 7–46 Same-patient CRAT recurrences were described in five reports 9,13,14,19,24 for a total of 68 cases of CRAT among 63 patients. Table 1 provides demographic details.…”

Section: Resultsmentioning

confidence: 98%

Catheter-related right atrial thrombosis

2019

View full text Add to dashboard Cite

Introduction: Catheter-related right atrial thrombosis is an under-recognized complication of central venous catheter placement. We performed a retrospective review, characterizing clinical aspects of catheter-related right atrial thrombosis (CRAT). Methods: To identify cases, a literature search was conducted in PubMed and additional items selected by review of related items and bibliography review. Key clinical data were extracted and analyzed both in total and as stratified by hemodialysis versus non-hemodialysis groups. Results: A total of 68 catheter-related right atrial thrombosis events were reported in 63 patients (five recurrences, of which 4 involved catheter left in place following primary treatment). Median (interquartile range) time to CRAT diagnosis was longer among hemodialysis patients – 12 (4.0–24.0) weeks compared to 5.5 (1.8–16.1) weeks among non-hemodialysis patients. The most common presentations were asymptomatic in 16/68 (23.5%), fever/sepsis in 21/68 (30.9%), pulmonary embolism in 11/68 (16.2%), catheter dysfunction in 8/68 (11.8%), dyspnea in 8/68 (11.8%), and new murmur or valvular dysfunction in 8/68 (11.8%) patients. Primary treatment selection was anticoagulation in 33/68 (48.5%), surgical thrombectomy in 17/68 (25.0%), thrombolysis in 12/68 (17.6%), or no active therapy in 6/68 (8.8%) patients. Primary treatment failure for anticoagulation and thrombolysis was 27.3% and 33.3%, respectively. The most common rescue therapy was surgical thrombectomy, ultimately resulting in an overall rate of 26/62 (41.9%). Overall, per-patient mortality was 13/63 (20.6%). Intracardiac tip position – 27/34 (79.4%) – overshadowed thrombophilia – 16/63 (25.4%) – as a risk factor for CRAT. Conclusion: Catheter-related right atrial thrombosis is an underdiagnosed complication of central venous catheter placement. For the hemodialysis population, a fistula-first approach is advocated. While many instances were asymptomatic, the development of unexplained fever, dyspnea, catheter dysfunction, or new murmur should trigger a search for this complication.

show abstract

Section: Resultsmentioning

confidence: 98%

Catheter-related right atrial thrombosis

2019

View full text Add to dashboard Cite

show abstract

“…Subsequent echocardiographic identification of the catheter-attached fibrin-thrombin-cellular matrix or biomass is so common as to be considered generally benign. It is reported that portions of the fibrinthrombin biomass may remain adherent to the catheter or conversely may be sheared off and even remain in the venous system at the time of catheter removal through the skin [24][25][26]. As they are often identified in the subclavian veins, right atrium, superior vena cava (SVC) or right ventricle (RV), a knowledgeable echocardiographer will infer their presence and related etiology to a current or recently removed catheter [24][25][26].…”

Section: Discussionmentioning

confidence: 99%

Hemodialysis Catheter-related Masses Case Report the Pro Inflammatory State in Chronic Kidney Disease

2019

JCRC

View full text Add to dashboard Cite

Indwelling venous catheters provide essential functional vascular access for patients requiring emergent or urgent hemodialysis, though their long-term use is practically limited by known complications including increased rates of infection as compared with surgically created arteriovenous (AV) fistulas. Converging lines of evidence also support that chronic kidney disease (CKD) represents a pro-inflammatory state, an environment with active cellular and inflammatory pathobiology. Accordingly, implantation of catheters for even short-term use is associated with a fibrinthrombin-cellular matrix often forming around the catheter. This "biomass" long considered innocuous, can cause occlusion of the catheter, contributing to reduced flow rates during dialysis. It may also result in embolic injury of downstream structures. This case report identifies a complex catheter-related biomass remaining after removal of the hemodialysis catheter and focuses on two concerns. First, intravenous masses associated with the catheter, or remaining after removal may provoke embolic and direct hemodynamic-related injury. But perhaps less obvious is their potential linkage to vascular immunoreactivity found in CKD. This latter potential may need to be part of the larger discussion surrounding the outcomes of such pathologic immunoresponsiveness in CKD patients on hemodialysis. www.opastonline.com J Clin Rev Case Rep, 2019 Volume 4 | Issue 1 | 2 of 4 www.opastonline.com J Clin Rev Case Rep, 2019 Volume 4 | Issue 1 | 4 of 4 Copyright: ©2019 Dr. John D Rozich, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

show abstract

“…Acute and complete obstruction of the SVC is caused more often by thrombosis than by compression or infiltration by a tumor ( 2 ). Risk factors for the formation of thrombus in the SVC include a hypercoagulable state in patients with malignancy, damage to the intima of the SVC from central venous catheters, and venous stasis from extraluminal compression ( 3 , 4 ). The most common causes are bronchogenic carcinoma (small-cell lung cancer and [less frequently] NSCLC) ( 5 ) and lymphoma.…”

Section: Discussionmentioning

confidence: 99%

Combined rheolytic thrombectomy and stent placement in SVC and brachiocephalic vein thrombosis due to metastatic lymphadenopathy

Ptohis¹,

Lechareas²,

Poulou³

et al. 2015

Radiology Case Reports

View full text Add to dashboard Cite

The current management of neoplastic obstruction, SVC, and brachiocephalic vein thrombosis, especially of SVC, is based on the combined use of interventional (endovascular thrombolysis or thrombectomy, stent placement) and noninterventional (radiation, chemotherapy) means of treatment. We present the case of a forty-year-old woman with SVC and left brachiocephalic vein thrombosis secondary to lymph node metastasis of non-small-cell lung cancer. A combination of rheolytic thrombectomy (Angiojet device) and stent placement was performed for both venous sites with complete technical success. We discuss the principles of percutaneous rheolytic thrombectomy, its effectiveness, and potential complications.

show abstract

“We have a tenant” a right atrial thrombus related to a central catheter

Cited by 15 publications

References 4 publications

Catheter-related right atrial thrombosis

Catheter-related right atrial thrombosis

Hemodialysis Catheter-related Masses Case Report the Pro Inflammatory State in Chronic Kidney Disease

Combined rheolytic thrombectomy and stent placement in SVC and brachiocephalic vein thrombosis due to metastatic lymphadenopathy

Contact Info

Product

Resources

About